Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits

American Journal of Clinical Nutrition

Volumn 64, Issue 4, 1996, Pages 587-593

  Lussier Cacan, Suzanne ^a   Xhignesse, Marianne ^b   Piolot, Alain ^b   Selhub, Jacob ^b   Davignon, Jean ^b   Genest Jr , Jacques ^b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NONE

Author keywords

creatinine; folic acid; health; pyridoxal phosphate; Total homocysteine; vitamin B 12

Indexed keywords

ALBUMIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; URIC ACID;

ARTICLE; BODY MASS; CATALYSIS; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC PREDISPOSITION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; REGRESSION ANALYSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0029786934     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/64.4.587     Document Type: Article

References (36)

1. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-8.
2. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS. Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, Inc, 1995:1279-327.
3. Kang S-S, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
4. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
5. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
6. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-76.
7. Nilsson K, Gustafson L, Fäldt R, Andersson A, Hultberg B. Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 1994;24:600-6.
8. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middleaged and elderly subjects. J Intern Med 1994;236:633-41.
9. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
10. Pancharuniti N, Lewis CA, Sauberlich HE, et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994;59:940-8.
11. Hopkins PN, Wu LL, Wu J, et al. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1314-20.
12. 6, pyridoxal phosphate, and folate. Am J Cardiol 1995;75:1107-11.
13. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995;92:2825-30.
14. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87.
15. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
16. Malinow MR, Levenson J, Giral P, et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 1995;114:175-83.
17. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-10.
18. Lipid Research Clinics Program. Manual of laboratory operations. Vol 1. Lipid and lipoprotein analysis. Washington, DC: US Government Printing Office, 1974. (Department of Health, Education and Welfare-NIH Publication no. 628.)
19. Allain CB, Poon LS, Chan FCS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
20. Sampson EJ, Demers LM, Krieg AF. Faster enzymatic procedure for serum triglycerides. Clin Chem 1975;21:1983-5.
21. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
22. Tamura T, Freeberg LE, Cornwell PE. Inhibition by EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem 1990;36:1993(technical brief).
23. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of pyridoxal 5′-phosphate. Clin Chem 1983;29:642-4.
24. Santé Québec. Et votre coeur, ça va? Rapport de l'enquête québécoise sur la santé cardiovasculaire 1990. (And how is your heart? Report of the Quebec Heart Health Survey 1990.) Montréal: Ministère de la Santé et des Services sociaux, Gouvernement du Québec, 1994:1-159(in French).
25. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995;1526:1526-33.
26. Wu LL, Wu J, Hunt SC, et al. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem 1994;40:552-61.
27. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994;40:873-81.
28. Malinow MR. Homocyst(e)ine and arterial occlusive diseases. J Intern Med 1994;236:603-17.
29. Stampfer MJ, Malinow MR, Willett W, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
30. Heart and Stroke Foundation of Canada. Cardiovascular disease in Canada. Ottawa, Canada: Heart and Stroke Foundation of Canada, 1991.
31. Kang S-S, Wong PWK, Cook HY, Norusis M, Messer JV. Proteinbound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 1986;77:1482-6.
32. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989;79:139-46.
33. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975;24:721-35.
34. Brattström L, Lindgren A, Israelsson B, et al. Hyperhomocysteinaemia in stroke, prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992;22:214-21.
35. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995;10:111-3.
36. Christensen B, Frosst P, Goyette P, et al. Methylenetetrahydrofolate reductase in premature CAD: correlation of enzymatic activity and thermolability with genotype and plasma homocysteine. Circulation 1995;92(suppl 1):103(abstr).